Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Side-by-side look at the strengths and weaknesses of zero-based budgeting and envelope systems to help you decide which suits your goals.
28,655 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Investors with large gains can roll them into a Qualified Opportunity Fund within 180 days, deferring the initial tax...
Coinbase CEO Brian Armstrong sparks a polarized debate by asking if Bitcoin's bottom is in, triggering thousands of v...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
Marvell Technology is poised to release earnings later this week, with investors focused on AI chip orders and optica...
A fresh inflation read is shifting how Social Security COLAs may grow next year. Analysts say the inflation report re...
Ripple asserts that CFO offices are moving crypto from pilots to production, targeting payroll and vendor payments. X...
SanDisk moved down about 5% after reporting strong Q4 results, fueling a sharp debate on whether the AI-led rally in ...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
After a sharp early-2026 retreat, Shopify looks set to re-rate as cash flow strengthens, a new buyback supports the s...
Bitcoin holds near a critical level as CME's volatility futures near launch, stoking bets on a push toward the mid-80...
Global markets slide as diplomatic talks stall and tensions rise around the Strait of Hormuz, driving a broad sell-of...